Cytek Biosciences, Inc. (CTKB) total liabilities

Total liabilities · fiscal 2025
$119.80M

Cytek Biosciences, Inc. (CTKB) had total liabilities of $119.80M at the end of fiscal 2025 (December 31, 2025). That is 15.5% higher than the $103.76M of fiscal 2024. Figures as of 18 Nov 2026, 18:17 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$119.80M
Change on fiscal 2024
+15.5%
Growth, 5 years
+23.5% a year
Highest on record
$119.80Mfiscal 2025
Lowest on record
$41.69Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Cytek Biosciences, Inc. total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities grew at a compound 23.5% a year. Across the 6 fiscal years on record (2020–2025), the highest was $119.80M in fiscal 2025 and the lowest $41.69M in fiscal 2020.

History · 6 fiscal years

Total liabilities by fiscal year

Cytek Biosciences, Inc. total liabilities, year by year

Cytek Biosciences, Inc. (CTKB) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$119.80M 15.5% up
2024$103.76M 2.3% up
2023$101.39M 7.9% up
2022$93.93M 62.2% up
2021$57.92M 38.9% up
2020$41.69M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

More on CTKB

Cytek Biosciences, Inc., figure by figure

Cytek Biosciences, Inc. (CTKB) overview: price, valuation and scorecard

Cytek Biosciences, Inc. total liabilities: questions and answers

How large are Cytek Biosciences, Inc.'s total liabilities?

Cytek Biosciences, Inc. (CTKB) had total liabilities of $119.80M at the end of fiscal 2025 (December 31, 2025). That is 15.5% higher than the $103.76M of fiscal 2024.

What is the growth rate of Cytek Biosciences, Inc.'s total liabilities?

Over the five fiscal years to 2025 total liabilities grew at a compound 23.5% a year.

What are the highest and lowest total liabilities figures on record for Cytek Biosciences, Inc.?

Across the 6 fiscal years on record (2020–2025), the highest was $119.80M in fiscal 2025 and the lowest $41.69M in fiscal 2020.

How is Cytek Biosciences, Inc.'s total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Cytek Biosciences, Inc. it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Cytek Biosciences, Inc. (CTKB) total liabilities”, data as of 18 November 2026. https://funkfolio.com/stock/CTKB/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.